Nouvelle-Zélande - anglais - Ministry for Primary Industries

schering-plough animal health limited - canine parvovirus (attenuated); canine distemper virus (attenuated) - canine parvovirus (attenuated) 0 vaccine; canine distemper virus (attenuated) 0 vaccine - vaccine

Nouvelle-Zélande - anglais - Ministry for Primary Industries

virbac new zealand limited - canine parvovirus (attenuated); canine adenovirus type 2 (attenuated); canine parainfluenza virus (attenuated); canine distemper virus (attenuated) - canine parvovirus (attenuated) 0 vaccine; canine adenovirus type 2 (attenuated) 0 vaccine; canine parainfluenza virus (attenuated) 0 vaccine; canine distemper virus (attenuated) 0 vaccine - vaccine

États-Unis - anglais - NLM (National Library of Medicine)

sanofi pasteur inc. - human rabies virus immune globulin (unii: 95f619atq2) (human rabies virus immune globulin - unii:95f619atq2) - human rabies virus immune globulin 150 [iu] in 1 ml - rabies immune globulin (human) heat treated, imogam rabies – ht, in conjunction with the standard series of rabies vaccine vaccinations, is indicated for individuals suspected of exposure to rabies, particularly severe exposure, with one exception: persons who have been previously immunized with rabies vaccine. previously immunized persons are those who have had a documented rabies virus neutralizing antibody titer and who have completed one of the recommended regimens (pre-exposure or post-exposure) with a cell culture vaccine or another vaccine. administer only vaccine to these persons (i.e., post-exposure for a person previously vaccinated). (1) inject imogam rabies – ht, as promptly as possible after exposure, along with the first dose of vaccine. if initiation of treatment is delayed for any reason, still administer imogam rabies – ht and the first dose of vaccine, regardless of the interval between exposure and treatment. if rabies immune globulin (human) was not administered when vaccination was begun

Irlande - anglais - HPRA (Health Products Regulatory Authority)

intervet ireland limited - canine parainfluenza virus strain cornell (live) - lyophilisate and solvent for suspension for injection - canine parainfluenza virus

Australie - anglais - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - bordetella bronchiseptica (inactivated cell free extract; canine adeno virus type 2; canine distemper virus - living; canine parainfluenza virus; canine parvo virus type 2; thiomersal - parenteral liquid/solution/suspension - bordetella bronchiseptica (inactivated cell free extract vaccine-microbial active 0.0 p; canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus - living vaccine-viral active 0.0 p; canine parainfluenza virus vaccine-viral active 0.0 p; canine parvo virus type 2 vaccine-viral active 0.0 p; thiomersal mercury other 0.1 mg/ml - immunotherapy - dog | bitch | castrate | puppy - bordetella bronchiseptica | canine distemper | canine parainfluenza | canine parvovirus | hepatitis :- infectious | canine adenovirus type 1 | canine adenovirus type 2 | canine cough syndrome | infectious canine hepatitis | infectious tracheobronchitis | parvovirus

Australie - anglais - APVMA (Australian Pesticides and Veterinary Medicines Authority)

fort dodge australia pty limited - canine adeno virus type 2 strain v197 | canine distemper virus strain onderstepoort | canine parvo virus k3i strain - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 1 | canine adenovirus - type 2 | canine distemper | canine parvovirus | disease | parvovirus

Australie - anglais - APVMA (Australian Pesticides and Veterinary Medicines Authority)

fort dodge australia pty limited - canine adeno virus type 2 strain v197 | canine distemper virus strain onderstepoort | canine parainfluenza type 2 | canine parvo virus k3i strain - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 1 | canine adenovirus - type 2 | canine distemper | canine parainfluenza | canine parvovirus | disease | parvovirus

Australie - anglais - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim pty limited, vetmedica division - canine distemper | hepatitis canine = canine adenovirus | parvovirus - live - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 1 | canine adenovirus - type 2 | canine distemper | canine parvovirus | parvovirus

Australie - anglais - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim pty limited, vetmedica division - canine distemper | hepatitis canine = canine adenovirus | canine parainfluenza virus | canine parvo virus - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 1 | canine adenovirus - type 2 | canine distemper | canine parainfluenza | canine parvovirus | parvovirus

Australie - anglais - APVMA (Australian Pesticides and Veterinary Medicines Authority)

fort dodge australia pty limited - canine distemper | canine adeno virus type 2 | canine parvo virus - immunotherapy - dog | bitch | castrate | puppy - canine distemper | canine parvovirus | hepatitis :- infectious | canine adenovirus type 1 | canine adenovirus type 2 | infectious canine hepatitis | parvovirus